- Home
- DMRC vs CATX Comparison
DMRC vs CATX Comparison
Compare DMRC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- CATX
- Stock Information
- Founded
- DMRC 2008
- CATX 1983
- Country
- DMRC United States
- CATX United States
- Employees
- DMRC N/A
- CATX N/A
- Industry
- DMRC EDP Services
- CATX Medical/Dental Instruments
- Sector
- DMRC Technology
- CATX Health Care
- Exchange
- DMRC Nasdaq
- CATX Nasdaq
- Market Cap
- DMRC 748.5M
- CATX 782.7M
- IPO Year
- DMRC N/A
- CATX N/A
- Fundamental
- Price
- DMRC $38.00
- CATX $3.20
- Analyst Decision
- DMRC Buy
- CATX Strong Buy
- Analyst Count
- DMRC 3
- CATX 9
- Target Price
- DMRC $34.00
- CATX $17.25
- AVG Volume (30 Days)
- DMRC 132.8K
- CATX 1.4M
- Earning Date
- DMRC 11-14-2024
- CATX 02-12-2025
- Dividend Yield
- DMRC N/A
- CATX N/A
- EPS Growth
- DMRC N/A
- CATX N/A
- EPS
- DMRC N/A
- CATX N/A
- Revenue
- DMRC $39,044,000.00
- CATX $1,557,000.00
- Revenue This Year
- DMRC $22.36
- CATX N/A
- Revenue Next Year
- DMRC $20.74
- CATX N/A
- P/E Ratio
- DMRC N/A
- CATX N/A
- Revenue Growth
- DMRC 19.09
- CATX N/A
- 52 Week Low
- DMRC $21.00
- CATX $2.70
- 52 Week High
- DMRC $43.43
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- DMRC 61.05
- CATX 28.06
- Support Level
- DMRC $35.60
- CATX $2.70
- Resistance Level
- DMRC $39.16
- CATX $3.33
- Average True Range (ATR)
- DMRC 1.97
- CATX 0.29
- MACD
- DMRC 0.11
- CATX 0.27
- Stochastic Oscillator
- DMRC 77.01
- CATX 34.97
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers, and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.